Free Trial

Nomura Asset Management Co. Ltd. Purchases New Position in Healthpeak Properties, Inc. (NYSE:DOC)

Healthpeak Properties logo with Finance background

Nomura Asset Management Co. Ltd. bought a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor bought 1,107,012 shares of the real estate investment trust's stock, valued at approximately $25,317,000. Nomura Asset Management Co. Ltd. owned 0.16% of Healthpeak Properties as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. HM Payson & Co. purchased a new position in shares of Healthpeak Properties in the 3rd quarter valued at about $25,000. S.A. Mason LLC purchased a new position in Healthpeak Properties in the third quarter worth approximately $26,000. Rise Advisors LLC acquired a new position in Healthpeak Properties during the 3rd quarter worth approximately $29,000. Fortitude Family Office LLC purchased a new stake in shares of Healthpeak Properties in the 3rd quarter valued at approximately $32,000. Finally, Barrett & Company Inc. acquired a new stake in shares of Healthpeak Properties in the 3rd quarter valued at $33,000. 93.57% of the stock is owned by hedge funds and other institutional investors.

Healthpeak Properties Trading Down 0.9 %

Shares of NYSE DOC traded down $0.19 during midday trading on Wednesday, reaching $21.25. 3,642,838 shares of the stock were exchanged, compared to its average volume of 5,650,140. The stock has a 50 day moving average price of $22.00 and a 200-day moving average price of $21.34. The company has a current ratio of 1.31, a quick ratio of 1.31 and a debt-to-equity ratio of 0.93. The company has a market capitalization of $14.86 billion, a P/E ratio of 45.21, a P/E/G ratio of 2.38 and a beta of 1.13. Healthpeak Properties, Inc. has a 52-week low of $16.01 and a 52-week high of $23.26.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 EPS for the quarter, missing the consensus estimate of $0.44 by ($0.32). Healthpeak Properties had a net margin of 12.10% and a return on equity of 3.53%. The business had revenue of $700.40 million during the quarter, compared to analyst estimates of $682.51 million. During the same quarter in the previous year, the company posted $0.45 earnings per share. The business's revenue for the quarter was up 25.9% compared to the same quarter last year. Equities research analysts expect that Healthpeak Properties, Inc. will post 1.8 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 5.65%. The ex-dividend date of this dividend was Monday, November 4th. Healthpeak Properties's payout ratio is currently 255.32%.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the stock. Deutsche Bank Aktiengesellschaft upgraded shares of Healthpeak Properties from a "hold" rating to a "buy" rating and boosted their price objective for the stock from $20.00 to $28.00 in a research report on Monday, October 21st. Wells Fargo & Company reduced their price target on shares of Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating for the company in a research report on Tuesday. StockNews.com lowered Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Wednesday, October 30th. Evercore ISI boosted their target price on Healthpeak Properties from $25.00 to $26.00 and gave the company an "outperform" rating in a report on Monday, September 16th. Finally, Scotiabank raised their price target on Healthpeak Properties from $23.00 to $24.00 and gave the stock a "sector outperform" rating in a research note on Monday, September 9th. One investment analyst has rated the stock with a sell rating, five have given a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $22.93.

View Our Latest Research Report on DOC

Healthpeak Properties Company Profile

(Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Featured Articles

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

Should you invest $1,000 in Healthpeak Properties right now?

Before you consider Healthpeak Properties, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.

While Healthpeak Properties currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines